Circe Bioscience
PrivateLast Round
Seed
Sep 12, 2024
Total Funding Raised
$13.37M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Circe Bioscience operates in Energy & Sustainability and is based in Waltham, Massachusetts. Its latest recorded funding round was a Seed round in September 2024.
Circe Bioscience is a biotechnology company that develops gas fermentation technology to convert carbon dioxide into sustainable, nature-identical fats, oils, and other organic compounds.
Sector
Energy & Sustainability
Verticals
Biotechnology, Carbon Capture, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Circe Bioscience Comparables
Compare Circe Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| COLIPI | 84% | |
| Green-On | 84% | |
| Seminal Biosciences | 82% |
For institutional investors. Book with your work email.
Circe Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 12, 2024 | ||||
| Grant | Jul 11, 2024 | ||||
| Grant | May 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Circe Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bee Partners | Seed |
| Climate Capital | Seed |
| Elementum Ventures | Seed |
| Exceptional Ventures | Seed |
| Ponderosa Ventures | Seed |
| Safar Partners | Seed |
| Undeterred Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 3300% MoM, from 12 to 408.
- Sep 12, 2024
$5M round with participation from Bee Partners and Climate Capital.
For institutional investors. Book with your work email.
Circe Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Circe Bioscience's valuation, stock price, and market status.
Is Circe Bioscience a public or private company?
Circe Bioscience is a private company.
What is the current stock price of Circe Bioscience?
Circe Bioscience is a private company, so its shares have no public market price. Caplight tracks Circe Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Circe Bioscience worth (valuation)?
Valuation information for Circe Bioscience is not publicly available.
Can I buy Circe Bioscience stock?
Circe Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Circe Bioscience's last funding round?
Circe Bioscience's most recent funding round was Seed on September 12, 2024.
Who are the main investors in Circe Bioscience?
Key investors in Circe Bioscience include Bee Partners, Climate Capital, Elementum Ventures, Exceptional Ventures, Ponderosa Ventures.
Will Circe Bioscience IPO soon?
No public IPO plans have been announced for Circe Bioscience.
How can I track Circe Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Circe Bioscience's shares on secondary markets.